How Will The Limited Supply Of Antibody Drugs For COVID-19 Be Allocated?


Eli Lilly researchers prepare cells to produce possible COVID-19 antibodies in a laboratory in Indianapolis. The drugmaker has asked the U.S. government to allow emergency use of its experimental antibody therapy.

Experimental medicines have the potential to help people with COVID-19 avoid hospitalization. The scarce supply of the treatments would have to be rationed, if regulators OK their use.

(Image credit: David Morrison/AP)

Previous articleBig Yikes: Dry & Cold Weather Can Deplete Collagen? Here’s What To Do
Next articleHow Poor Sleep Might Be Affecting Your Gut + What To Do About It


Please enter your comment!
Please enter your name here